← Leaderboards
Patrice M Milos
Helicos Bioscience Corporation
$2,776,090
Attributed
$2,776,090
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2010–18$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,776,090 · 3
By mechanism
R44$1,392,548 · 1
R01$1,083,872 · 1
R43$299,670 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTechnologyBaseMeasurementGenomicsSpecimenNucleotidesHuman DiseaseHeart DiseasesCostGenome SequencingGovernmentBiologicalBiologyGene ExpressionDna SequenceInvestigationGenomeCommunitiesDiagnosticDiabetes MellitusFundingHuman GenomeComplementary Dna
Grant awards (7)
Combining Next-Generation Sequencing and Advanced Algorithms to Elucidate Tumor Heterogeneity$299,670
R43 · FY2018 · CA · contact PI
Attomole-Level High-Throughput Genomics$505,768
R44 · FY2012 · HG · contact PI
True Direct Single Molecule RNA Sequencing$32,628
R01 · FY2012 · HG · contact PI
Attomole-Level High-Throughput Genomics$740,380
R44 · FY2011 · HG · contact PI
True Direct Single Molecule RNA Sequencing$522,744
R01 · FY2011 · HG · contact PI
True Direct Single Molecule RNA Sequencing$528,500
R01 · FY2010 · HG · contact PI
Attomole-Level High-Throughput Genomics$146,400
R44 · FY2010 · HG · contact PI